Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Pancreatic Neoplasms 3Carcinoma 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thrombocythemia, Essential 1Prostatic Neoplasms 1Primary Myelofibrosis 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Fibrolamellar hepatocellular carcinoma 1Diabetes Mellitus, Insulin-Dependent, 12 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Biliary Tract Neoplasms 1Adenocarcinoma 1

Interventions

ruxolitinib 4Specimen Handling 2Biopsy 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2talazoparib 1poly ICLC 1piperine 1fludarabine phosphate 1fludarabine 1fedratinib 1demethoxycurcumin 1bomedemstat 1X-Rays 1Whole-Body Irradiation 1Watchful Waiting 1Tacrolimus 1Stem Cell Transplantation 1Positron-Emission Tomography 1N(4)-oleylcytosine arabinoside 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Injections 1Hematopoietic Stem Cell Transplantation 1Decitabine 1Cyclophosphamide 1Curcumin 1Aspirin 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Thrombocythemia, Essential × poly ICLC × Clear all
NCT05025488 2025-04-06

Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm

Icahn School of Medicine at Mount Sinai

Phase 1 Recruiting
10 enrolled
Myeloid

Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡